BVMF/A1ZN34 (BVMF/A1ZN34)

Brazil Stock Exchange: BVMF/A1ZN34 · BRL

R$151

-2.10 (-1.4%)· Recorded snapshot

Market cap	1.4T
Revenue (ttm)	317.9B
Net income (ttm)	54.1B
EPS (ttm)	R$6.00
P/E (trailing)	25.2x
P/E (forward)	15.8x
Dividend	R$2.71 (1.79%)
Volume	3,203
Beta	0.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 317.9B
Net income (ttm): 54.1B
EPS (ttm): R$6.00
P/E (trailing): 25.2x
P/E (forward): 15.8x
Market cap: 1.4T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E15.8

P25 n/aP50 n/aP75 n/a

Trailing P/E25.2

P25 n/aP50 n/aP75 n/a

ROE22

P25 n/aP50 n/aP75 n/a

ROIC16.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/A1ZN34 indicators

Market & fundamental data

Available fields

244

Groups with data

Currency

USD

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United Kingdom
Country code	BR
Earnings date	2026-10-30
Employees	96,100
Employees change	4,400
Employees growth	4.89%
Enterprise value	BRL 1.6T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1992
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRA1ZNBDR003
Last earnings date	2026-07-27
Last refreshed	2026-10-28
Last stock split date	2026-02-02
Last stock split type	Reverse
Market cap	BRL 1.4T
Next earnings date	2026-10-30
Price	BRL 151.15
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bvmf/A1ZN34
Website	https://www.astrazeneca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	84.65x
Average P/E ratio (3Y)	30.99x
Average P/E ratio (5Y)	130.79x
Earnings yield	3.97%
EV/Earnings	28.87x
EV/EBIT	19.46x
EV/EBITDA	14.11x
EV/FCF	28.27x
EV/Sales	4.75x
FCF / EV yield	3.54%
FCF yield	3.91%
Forward P/E	15.78x
Graham number	60.21377
Graham upside	-60.16%
Lynch fair value	BRL 130.66
Lynch upside	-13.56%
P/(FCF - SBC) ratio	26.51x
P/(OCF - SBC) ratio	20.48x
P/B ratio	5.42x
P/E ratio	25.21x
P/FCF ratio	25.6x
P/OCF ratio	19.94x
P/S ratio	4.45x
Price/EBITDA ratio	13.49x
Sector forward P/E	11.33x
Sector P/E	41.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.42%
EBITDA margin	33%
Effective tax rate	16.95%
FCF margin	16.77%
Gross margin	81.69%
Operating margin	24.42%
Pretax margin	20.51%
Profit margin	17.02%
Profit per employee	BRL 563,149
Profitable quarters	18
Profitable years	36
Revenue per employee	BRL 3.3M
ROA	8.21%
ROA (5Y)	5.95%
ROCE	17.78%
ROE	21.96%
ROE (5Y)	13.03%
ROIC	16.43%
ROIC (5Y)	13.29%
SBC / revenue	0.6%
Tax / revenue	3.48%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.84%
EPS growth (Q)	2.55%
EPS growth (QoQ)	-18.27%
EPS growth 10Y	14.33%
EPS growth 3Y	19.13%
EPS growth 5Y	18.4%
EPS growth years	4
FCF growth	-4.55%
FCF growth (Q)	-22.92%
FCF growth (QoQ)	-25.25%
FCF growth 3Y	5.66%
FCF growth 5Y	14.81%
Gross profit growth	7.69%
Gross profit growth (Q)	7.25%
Gross profit growth 3Y	9.19%
Gross profit growth 5Y	17.24%
Net income growth	25.93%
Net income growth (Q)	2.33%
Net income growth (QoQ)	-18.6%
Net income growth 3Y	19.23%
Net income growth 5Y	22.6%
Net income growth years	4
OCF growth	2.32%
OCF growth (Q)	-15.39%
OCF growth (QoQ)	-14.71%
OCF growth 10Y	14.02%
OCF growth 3Y	10.41%
OCF growth 5Y	16.27%
Operating income growth	5.8%
Operating income growth (Q)	2.88%
Operating income growth 3Y	9.95%
Operating income growth 5Y	31.31%
Revenue growth	8.61%
Revenue growth (Q)	6.41%
Revenue growth (QoQ)	0.63%
Revenue growth 10Y	9.81%
Revenue growth 3Y	11.32%
Revenue growth 5Y	15.75%
Revenue growth quarters	13
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -15.7B
Depreciation and amortization	BRL 28.3B
EBIT	BRL 77.6B
EBITDA	BRL 104.9B
EPS	BRL 6.00
Financing cash flow	BRL -39.8B
Free cash flow	BRL 55.3B
Free cash flow minus SBC	BRL 53.4B
Gross profit	BRL 259.7B
Income taxes	BRL 11.1B
Investing cash flow	BRL -42.2B
Net borrowing	BRL -10.1B
Net cash flow	BRL -11.1B
Net income	BRL 54.1B
Operating cash flow minus SBC	BRL 69.1B
Operating income	BRL 77.6B
Revenue	BRL 317.9B
Stock-based compensation	BRL 1.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.58
Book value per share	BRL 168.00
Debt / EBITDA	1.57
Debt / equity	0.64
Debt / FCF	3.03
Goodwill	BRL 113.8B
Interest coverage	10.64
Long-term assets	BRL 449.9B
Long-term liabilities	BRL 169.7B
Net cash (debt)	BRL -141.9B
Net cash / market cap	-10.03%
Net debt / EBITDA	1.35
Net debt / equity	0.54
Net debt / FCF	2.57
Piotroski F-Score	7
Property, plant and equipment	BRL 87.6B
Shareholders' equity	BRL 261B
Tangible book value	BRL -44.6B
Tangible book value per share	BRL -28.76
Total assets	BRL 600.1B
Total cash	BRL 25.7B
Total debt	BRL 167.6B
Total liabilities	BRL 339.2B
WACC	5.23%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	BRL 150.2B
Current liabilities	BRL 169.5B
Current ratio	0.89
Inventory turnover	1.68
Net working capital	BRL -11.5B
Quick ratio	0.66
Working capital	BRL -18.6B
Working capital turnover	-77.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.03%
Dividend growth	-2.35%
Dividend growth (3Y)	5.09%
Dividend growth years	3
Dividend payment date	2026-09-14
Dividend payment years	5
Dividend payout frequency	Semi-Annual
Dividend per share	BRL 2.71
Dividend yield	1.79%
Ex-dividend date	2026-08-06
Last dividend	BRL 0.87
Payout ratio	45.73%
Shareholder yield	1.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 149.72
1D price change	-1.37%
1M price change	4.86%
1M total return	4.86%
1W price change	9.22%
1W total return	9.22%
1Y price change	0.62%
1Y return CAGR	2.29%
1Y total return	2.29%
20-day SMA	BRL 138.74
200-day SMA	BRL 154.69
3M price change	5.75%
3M total return	6.42%
3Y price change	41.13%
3Y return CAGR	14.32%
3Y total return	49.43%
50-day SMA	BRL 140.05
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 190.40
52-week high date	2026-02-18
52-week low	BRL 129.06
52-week low date	2026-10-05
6M price change	-4.1%
6M total return	-3.49%
All-time high	BRL 190.40
All-time high date	2026-02-18
All-time low	BRL 93.74
All-time low date	2022-10-20
Average true range (ATR)	BRL 5.39
Average volume	1.5K
Beta (5Y)	0.21
Change from 52-week high	-20.61%
Change from 52-week low	17.12%
Change from all-time high	-20.61%
Change from all-time low	61.24%
Change from open	-0.48%
Day's gap	-0.89%
Dollar volume	BRL 484,133
High price	BRL 152.89
Low price	BRL 150.70
Monthly RSI	52.77
Open price	BRL 151.88
Position in 52-week range	20.55%
Previous close	BRL 153.25
Price vs 150-day SMA	0.95%
Price vs 20-day SMA	8.94%
Price vs 200-day SMA	-2.29%
Price vs 50-day SMA	7.92%
Relative volume	2.2
RSI	59.55
Sharpe ratio	0.07
Sharpe ratio (3Y)	0.39
Sortino ratio	0.28
Sortino ratio (3Y)	0.78
Volume	3.2K
Weekly RSI	53.36
YTD price change	-10.38%
YTD total return	-8.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.5B
Shares change (QoQ)	-0.06%
Shares change (YoY)	-0.03%
Shares held by insiders	0.04%
Shares held by institutions	74.28%

Deeper analysis on BVMF/A1ZN34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/A1ZN34 report

Is a complete BVMF/A1ZN34 research report available?

No complete published report is available for bvmf/A1ZN34 (BVMF/A1ZN34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/A1ZN34 (BVMF/A1ZN34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/A1ZN34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/A1ZN34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/A1ZN34

Frequently asked questions